AETHLON MEDICAL INC (AEMD) › Shareholders' EquityAETHLON MEDICAL INC (AEMD) — Shareholders' EquityAnnual figures by period end, from SEC filings.2010-03-31: -$4.40M2011-03-31: -$5.98M2012-03-31: -$9.30M2013-03-31: -$9.14M2014-03-31: -$14.95M2015-03-31: $615.5K2016-03-31: $1.55M2017-03-31: $676.4K2018-03-31: $6.13M2019-03-31: $2.43M2020-03-31: $9.41M2021-03-31: $9.43M2022-03-31: $16.99M2023-03-31: $15.06M2024-03-31: $5.77M2025-03-31: $5.12M2026-03-31: $4.89M$4.89M2010-03-31Shareholders' Equity (USD)2026-03-31Period endedShareholders' EquityChange YoYSource filing2026-03-31$4.89M-4.6%2026-06-10Balance as of period end2025-03-31$5.12M-11.1%2026-06-10Balance as of period end2024-03-31$5.77M-61.7%2026-06-10Balance as of period end2023-03-31$15.06M-11.3%2025-06-26Balance as of period end2022-03-31$16.99M+80.2%2024-06-27Balance as of period end2021-03-31$9.43M+0.2%2022-06-28Balance as of period end2020-03-31$9.41M+288.0%2021-06-24Balance as of period end2019-03-31$2.43M-60.5%2020-06-25Balance as of period end2018-03-31$6.13M+806.9%2019-07-01Balance as of period end2017-03-31$676.4K-56.4%2018-06-08Balance as of period end2016-03-31$1.55M+152.3%2017-06-28Balance as of period end2015-03-31$615.5K—2016-06-29Balance as of period end2014-03-31-$14.95M—2015-07-13Balance as of period end2013-03-31-$9.14M—2014-07-15Balance as of period end2012-03-31-$9.30M—2014-07-15Balance as of period end2011-03-31-$5.98M—2013-07-15Balance as of period end2010-03-31-$4.40M—2012-06-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)